ConductScience.org, home

Paper8082292

Reduced NK activity correlates with active disease in HIV- patients with multidrug-resistant pulmonary tuberculosis.

Ratcliffe LT and 3 others. Clin Exp Immunol, 1994. Cited by 39 papers, by iCite.

Cite this record

ConductScience Library. Reduced NK activity correlates with active disease in HIV- patients with multidrug-resistant pulmonary tuberculosis. Papers, record 8082292. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8082292

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Reduced NK activity correlates with active disease in HIV- patients with multidrug-resistant pulmonary tuberculosis.
PubMed
Journal
Clin Exp Immunol
PubMed
Year
1994
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
39
iCite
Relative citation ratio, by iCite
0.88
iCite
Revised in PubMed
2019-05-12
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ratcliffe LTL T
2Lukey PTP T
3MacKenzie CRC R
4Ress SRS R

Source PubMed

Download CSV of authors

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HIV SeronegativityMajor topic
Killer Cells, NaturalMajor topic
Tuberculosis, Multidrug-ResistantMajor topic
Tuberculosis, PulmonaryMajor topic
Adult
Case-Control Studies
Cytotoxicity, Immunologic
Female
Humans
Immunity, Cellular
Immunophenotyping
Interleukin-2
Killer Cells, Lymphokine-Activated
Lymphocyte Activation
Lymphocyte Subsets
Male
Mycobacterium tuberculosis
Prospective Studies
Skin Tests
Sputum

Source PubMed

Download CSV of topics

References20

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11898601Natural killer cell-dependent mycobacteriostatic and mycobactericidal activity in human macrophages.J Immunol1991https://conductscience.org/library/papers/1898601PubMed
21736110The new tuberculosis.N Engl J Med1992https://conductscience.org/library/papers/1736110PubMed
31346797Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients.J Exp Med1992https://conductscience.org/library/papers/1346797PubMed
41616211An outbreak of tuberculosis caused by multiple-drug-resistant tubercle bacilli among patients with HIV infection.Ann Intern Med1992https://conductscience.org/library/papers/1616211PubMed
51352093Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis. A risk to patients and health care workers.Ann Intern Med1992https://conductscience.org/library/papers/1352093PubMed
61296597Multidrug-resistant tuberculosis.Ann Intern Med1992https://conductscience.org/library/papers/1296597PubMed
71501708Tuberculosis. Back to a frightening future.Nature1992https://conductscience.org/library/papers/1501708PubMed
81855997In vivo depletion of natural killer cell activity leads to enhanced multiplication of Mycobacterium avium complex in mice.Infect Immun1991https://conductscience.org/library/papers/1855997PubMed
91362540Emergence during unsuccessful chemotherapy of multiple drug resistance in a strain of Mycobacterium tuberculosis.Eur J Clin Microbiol Infect Dis1992https://conductscience.org/library/papers/1362540PubMed
105309084Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes.Bull World Health Organ1969https://conductscience.org/library/papers/5309084PubMed
112934798HLA-DR expression on cytotoxic T lymphocytes.Scand J Immunol1985https://conductscience.org/library/papers/2934798PubMed
123491726Interleukin-2 corrects defective NK activity of patients with leukemia.Comp Immunol Microbiol Infect Dis1986https://conductscience.org/library/papers/3491726PubMed
133553003Characterization, sequence determination, and immunogenicity of a 64-kilodalton protein of Mycobacterium bovis BCG expressed in escherichia coli K-12.Infect Immun1987https://conductscience.org/library/papers/3553003PubMed
142739140Enhanced natural killer cell activity in patients with pulmonary tuberculosis.Jpn J Med1989https://conductscience.org/library/papers/2739140PubMed
153151440CD8+ T lymphocytes in intracellular microbial infections.Immunol Today1988https://conductscience.org/library/papers/3151440PubMed
162683611Biology of natural killer cells.Adv Immunol1989https://conductscience.org/library/papers/2683611PubMed
172114810Analysis of immunologic mechanisms of high natural killer cell activity in tuberculous pleural effusions.Am Rev Respir Dis1990https://conductscience.org/library/papers/2114810PubMed
182164902Specific lysis of mycobacterial antigen-bearing macrophages by class II MHC-restricted polyclonal T cell lines in healthy donors or patients with tuberculosis.Clin Exp Immunol1990https://conductscience.org/library/papers/2164902PubMed
192124157Drug resistance and tuberculosis elimination.Bull Int Union Tuberc Lung Dis1990https://conductscience.org/library/papers/2124157PubMed
201736751Evidence for in vivo generation of cytotoxic T cells. PPD-stimulated lymphocytes from tuberculous pleural effusions demonstrate enhanced cytotoxicity with accelerated kinetics of induction.Am Rev Respir Dis1992https://conductscience.org/library/papers/1736751PubMed

Download CSV of references

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 39 citations.

PMIDTitleJournalYearIn PapersSource
42756352Research progress on the role and dysregulation of NK cells in anti-tuberculosis immunity.Front Immunol2026https://conductscience.org/library/papers/42756352PubMed
37543504Rifampicin drug resistance and host immunity in tuberculosis: more than meets the eye.Trends Immunol2023https://conductscience.org/library/papers/37543504PubMed
37474556NK cell phenotypic profile during active TB in people living with HIV-evolution during TB treatment and implications for bacterial clearance and disease severity.Sci Rep2023https://conductscience.org/library/papers/37474556PubMed
37101462Attenuated Cytokine-Induced Memory-Like Natural Killer Cell Responses to Mycobacterium tuberculosis in Tuberculosis Patients.Infect Drug Resist2023https://conductscience.org/library/papers/37101462PubMed
35888979Immunosuppressive Mechanisms in Brucellosis in Light of Chronic Bacterial Diseases.Microorganisms2022https://conductscience.org/library/papers/35888979PubMed
25196698Natural killer cells: a coherent model for their functional role in Mycobacterium tuberculosis infection.J Innate Immun2015https://conductscience.org/library/papers/25196698PubMed
19251297CD4+ NK cells can be productively infected with HIV, leading to downregulation of CD4 expression and changes in function.Virology2009https://conductscience.org/library/papers/19251297PubMed
16474159Natural killer cell function is well preserved in asymptomatic human immunodeficiency virus type 2 (HIV-2) infection but similar to that of HIV-1 infection when CD4 T-cell counts fall.J Virol2006https://conductscience.org/library/papers/16474159PubMed
16120969Dendritic cells and natural killer cells in the pathogenesis of HIV infection.Immunol Res2005https://conductscience.org/library/papers/16120969PubMed
14523045Identification of App1 as a regulator of phagocytosis and virulence of Cryptococcus neoformans.J Clin Invest2003https://conductscience.org/library/papers/14523045PubMed
10193420Expression of killer inhibitory receptors on cytotoxic cells from HIV-1-infected individuals.Clin Exp Immunol1999https://conductscience.org/library/papers/10193420PubMed
9649576Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro.J Clin Invest1998https://conductscience.org/library/papers/9649576PubMed
9353012Interleukin-12 gene expression in human monocyte-derived macrophages stimulated with Mycobacterium bovis BCG: cytokine regulation and effect of NK cells.Infect Immun1997https://conductscience.org/library/papers/9353012PubMed
8962043Nutrition, immunity and infection: from basic knowledge of dietary manipulation of immune responses to practical application of ameliorating suffering and improving survival.Proc Natl Acad Sci U S A1996https://conductscience.org/library/papers/8962043PubMed
8705665Effects of anticoagulant, serum, and temperature on the natural killer activity of human peripheral blood mononuclear cells stored overnight.Clin Diagn Lab Immunol1996https://conductscience.org/library/papers/8705665PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8082292

GET https://conductscience.org/api/papers/v1/8082292/authors